Tumor volume regression during neoadjuvant chemoradiotherapy for esophageal cancer: a prospective study with weekly MRI.

Conclusion: Based on weekly MRI scanning during nCRT for esophageal cancer, a considerable decrease in tumor volume was observed during treatment. Volume regression and consequential anatomical changes suggest the possible benefit of adaptive radiotherapy. PMID: 32400242 [PubMed - as supplied by publisher]

https://www.ncbi.nlm.nih.gov/pubmed/32400242?dopt=Abstract

Source: Acta Oncologica - May 12, 2020 Category: Cancer & Oncology Authors: Defize IL, Boekhoff MR, Borggreve AS, van Lier ALHMW, Takahashi N, Haj Mohammad N, Ruurda JP, van Hillegersberg R, Mook S, Meijer GJ Tags: Acta Oncol Source Type: research